DS0408 -

Role of Ig and BCR class in the cell interaction supporting immune memory and impact for immune pathology – Ig-MemImpact

Submission summary

Persistent humoral immune memory against pathogens and vaccines is notably supported by two major long-lived players: plasma cells continuously secreting antibodies (Abs), and antigen (Ag)-watching memory B-cells. The latter are capable upon re-challenge by Ag to rapidly yield more abundant Abs, functionally diversified by class-switching, and with supposedly higher affinity than those from naive cells. Like T-cells, B-cells fall in various functional compartments notably regarding memory, the frontiers of which remains fuzzy. Whether B-cell receptor (BCR) class-switching significantly contributes to their functional split remains controversial. It is also clear that memory B-cells need support from T follicular helper (Tfh) cells and stromal cells of lymphoid organs, and there are indications that B-cells might also reciprocally modulate their supportive micro-environment.

Most but not all memory B-cells are class-switched, and memory responses to Ag include (but not only consist into) high affinity class-switched Abs. Class-switching can also sometimes shorten B-cell lifespan. Altogethrer, we clearly still have a very poor understanding of the impact of the class of membrane BCR and secreted Abs on immune response polarity and immune memory, and on the whole network of cell interactions which support immune responses in lymphoid tissues. More in-depth study is needed for B-cell intrinsic features connected to class-switching, and also for B-cell extrinsic features dependent from Tfh and the lymphoid stroma. With the global objective of better understanding the link between class switching and the processes of immune response polarization and immune memory, we will thus simultaneously consider not only B-cells but also their main partners, lymphoid stromal cells and Tfh, and develop models where B cells specifically produce one specific Ig class but with diversified BCR and TCR repertoires, and where Ag-specific cells can be followed, studied and eventually sorted. While various tools are available and will be developed along the project, implementing them into an ultimate model for fine studies of the cell interactions that support immune memory will by itself constitute one of the aims of the project, paving the way for future still more ambitious studies.

The project combines the expertise of Team 1 about B-cell intrinsic features, B-cell fate and class-switching, Team 2, with expertise in Tfh physiology and fate and Team 3 which masters the characterization of the stromal populations organizing lymphoid tissues and their functional cross-talk with B and Tfh lymphoid cells. Teams will jointly explore both BCR-class-dependent intrinsic B-cell phenotypes and B-cell impact on the other cell populations of lymphoid tissues.

B-cell memory is a major issue not only for basic immunology, but also for the vaccinology and immunopathology fields. The issue of long-term protection against pathogens after primary infection or vaccination is of increasing importance since vaccination in infancy is now widely proposed for the prevention of multiple infections (and HPV or HCV-associated sarcomas). Besides these benefits, it remains unclear to what extent post-vaccinal memory can ensure lifelong protection. This is of especially crucial interest for those pathogens potentially yielding more severe infections in adults than children.

Besides protection, humoral memory is also involved in long-term adverse reactions in auto-immune or allergic settings. Beyond basic immunology, the “immune memory issues” are thus both pertinent to prevention or treatment of infectious diseases on one hand, to immunotherapy of cancer of inflammatory diseases on the other hand, and finally to the long-term management of immunoallergic diseases, where in-depth understanding (and potentially control) of immune memory would be of clinical importance and might translate into effective immunotherapy protocols.

Project coordination

Michel COGNE (Contrôle de la réponse Immune)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

MICA U917 INSERM
CRIBL Contrôle de la réponse Immune
CPTP Centre de Physiopathologie de Toulouse-Purpan

Help of the ANR 689,648 euros
Beginning and duration of the scientific project: September 2016 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter